Navigating EU HTA: Your Roadmap to Success

Episode 1: The New EU HTA Landscape – Are You Ready?

We are excited to introduce our brand-new series of short videos dedicated to exploring the intricacies and challenges of navigating the EU Health Technology Assessment (HTA) Regulation. As we reach the end of Q1 2025, stakeholders across the healthcare spectrum have been adapting to the significant changes brought about by the application of the EU HTA Regulation.

In our first episode, we examine the journey since the Regulation came into force. We touch upon the establishment of the governance structure, the development of essential guidance, and the preparations by national HTA bodies for the pivotal joint clinical assessment (JCA) under the EU HTAR.

The implementation of this Regulation represents a seismic shift for all involved—pharmaceutical companies, medtech firms, HTA bodies, patient organizations, consultancies, and other stakeholders. From our own experience, internal preparations which we initiated when the Regulation entered into force in January 2022, have been crucial.

In this episode, we highlight the need for preparing your organization to ensure a smooth process and recommend steps you can take to develop a new internal framework to ensure readiness for success.

But this is just the beginning. Stay tuned for more bite-sized episodes where we will continue to share insights, practical advice, and success stories to help you navigate the evolving landscape of EU HTA.